This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Scripps Research Institute. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Yuyin Liu: Innovator in Coronavirus Treatment
Introduction
Yuyin Liu is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmaceutical research, particularly in the development of treatments for viral infections.
Latest Patents
Yuyin Liu holds a patent for "Protease inhibitors for treatment of coronavirus infections." This patent includes compounds of Formula (I), their pharmaceutically acceptable salts, and their pharmaceutical compositions. The compounds are identified as potent inhibitors of the main protease (M) of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). They are particularly useful in treating or preventing COVID-19 in affected individuals.
Career Highlights
Yuyin Liu is affiliated with The Scripps Research Institute, where he conducts his research and development work. His innovative approach to drug design has positioned him as a key figure in the fight against coronavirus infections.
Collaborations
Yuyin Liu has collaborated with notable colleagues, including Arnab Kumar Chatterjee and Jian Jeffrey Chen. Their combined expertise enhances the research efforts at The Scripps Research Institute.
Conclusion
Yuyin Liu's work in developing protease inhibitors represents a significant advancement in the treatment of COVID-19. His contributions to pharmaceutical research are invaluable in the ongoing battle against viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile